Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series

JAAD Case Reports(2021)10.1016/j.jdcr.2021.03.048Source: DataRank Database

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series is a research paper published in JAAD Case Reports (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.08)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Madison Grinnell ORCID,Thomas Vazquez ORCID,DeAnna Diaz ORCID,Preethi Thomas,Victoria P. Werth ORCID

Live enrichment

PubMed:33997219 PMC:PMC8105185 OpenAlex:https://openalex.org/W3153449433

National Institutes of Health

Grant: AR076766

NIAMS NIH HHS

Grant: R01 AR076766

National Institutes of Health

Grant: 5R01AR076766-04

A nonpsychoactive cannabinoid receptor-2 agonist to treat itch and inflammation in dermatomyositis

U.S. Department of Veterans Affairs

Biomedical Laboratory Research and Development, VA Office of Research and Development

Health Services Research and Development

FWCI

1.08

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2025

goldLicense: cc-by

journalhttp://www.jaadcasereports.org/article/S2352512621002472/pdf

publisherhttp://www.jaadcasereports.org/article/S2352512621002472/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352512621002472?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352512621002472?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jdcr.2021.03.048

Fields of Study

Systemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchPeripheral Neuropathies and Disorders03 medical and health sciences0302 clinical medicine

Keywords

MedicineSubacute cutaneous lupus erythematosusDermatologySystemic lupus erythematosusLupus erythematosusConnective tissue diseaseDiseasePathologyAutoimmune diseaseImmunologyAntibodyAntihypertensivesMedicationsDrug ReactionsProton-pump InhibitorsAutoimmune Skin DiseaseMedication Side EffectSubacute Cutaneous LupusSle, Systemic Lupus ErythematosusMedical DermatologyAna, Antinuclear AntibodyDi-Scle, Drug-Induced Subacute Cutaneous Lupus ErythematosusDrug-Induced Subacute Cutaneous LupusScle, Subacute Cutaneous Lupus ErythematosusPpis, Proton-pump InhibitorsRL1-803Case Series

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)